Finch Therapeutics Group (NASDAQ:FNCH) Upgraded by Zacks Investment Research to Hold

Finch Therapeutics Group stock has undergone multiple analysts rating changes in the recent past.  Finch Therapeutics Group Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

Shares of Finch Therapeutics Group traded down -$0.03 on Tuesday, reaching $11.97. 0 shares of the stock traded hands, compared to its average volume of 33624. Shares of Finch Therapeutics Group were trading at $11.97 on Tuesday. The firm’s 50 day moving average is $13.71 and its 200 day moving average is N/A.Finch Therapeutics Group has a 12 month low of $11.79 and a 12 month high of $22.50. While on yearly highs and lows, Finch Therapeutics Group’s today has traded high as $12.10 and has touched $11.79 on the downward trend. See More Analyst Rating at: RATING

Finch Therapeutics Group Earnings and What to expect: 

Finch Therapeutics Group last announced its earnings results on August 10th, 2021. The reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.04. The firm had revenue of $2.83 million for the quarter. Finch Therapeutics Group has generated $0.00 earnings per share over the last year. Earnings for Finch Therapeutics Group are expected to decrease in the coming year, from ($1.91) to ($2.28) per share. Finch Therapeutics Group has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 9th, 2021 based off prior year’s report dates.

Earnings for Finch Therapeutics Group are expected to decrease in the coming year, from ($1.91) to ($2.28) per share.

Finch Therapeutics Group (NASDAQ:FNCH) Moving Average Technical Analysis

5 day Moving Average is $12.01 And 5 day price change is -$0.63 (-5.00%)  with average volume for 5 day average is 38,460. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $13.33 and 20 day price change is -$1.05 (-8.06%) and average 20 day moving volume is 33,705. 50 day moving average is $13.71  and 50 day price change is -$1.40 ( -10.47%)  and with average volume for 50 days is : 33,766. 200 day moving average is N/A  and 200 day price change is N/A (N/A)  and with average volume for 200 days is : N/A.

Other owners latest trading in Finch Therapeutics Group :

  • On 10/12/2021 shares held by First Midwest Bank Trust Division were 26,344 which equates to market value of $0.34M and appx 0.00% owners of Finch Therapeutics Group
  • On 8/18/2021 shares held by Ikarian Capital LLC were 325,000 which equates to market value of $4.57M and appx 0.40% owners of Finch Therapeutics Group
  • On 8/17/2021 shares held by Woodline Partners LP were 53,371 which equates to market value of $0.75M and appx 0.00% owners of Finch Therapeutics Group
  • In total Institutional ownership equates to Institutional Ownership Percentage: 11.62% for Finch Therapeutics Group

See More Analyst Rating at: RATING